Sublingual Placebo
Sublingual Placebo is a pharmaceutical drug with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
2
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Use of Sublingual Melatonin Premedication in Geriatric Cataract Surgery
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy
Rectal Indomethacin Versus Rectal Indomethacin and Sublingual Nitrate for PEP Prevention
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy
Clinical Trials (6)
The Use of Sublingual Melatonin Premedication in Geriatric Cataract Surgery
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy
Rectal Indomethacin Versus Rectal Indomethacin and Sublingual Nitrate for PEP Prevention
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy
Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6